Detalles de la búsqueda
1.
Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry.
Gastric Cancer
; 27(1): 131-145, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37964032
2.
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
Gastric Cancer
; 24(2): 445-456, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32970266
3.
Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry.
Br J Cancer
; 117(6): 775-782, 2017 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28765618
4.
Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer.
Gastric Cancer
; 20(3): 465-474, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27599830
5.
MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer.
BMC Cancer
; 14: 656, 2014 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25197016
6.
Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry.
Clin Transl Oncol
; 26(7): 1674-1686, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38361134
7.
Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry.
J Cancer Res Clin Oncol
; 149(7): 4077-4089, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36042046
8.
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.
Ther Adv Med Oncol
; 15: 17588359231157641, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36895850
9.
Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial.
Eur J Cancer
; 145: 158-167, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33485079
10.
External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry.
Ther Adv Med Oncol
; 13: 17588359211019672, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34211587
11.
Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry.
PLoS One
; 15(7): e0235848, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32735623
12.
Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses.
Clin Colorectal Cancer
; 18(4): 269-279.e5, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31628043
13.
Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer.
Thromb Haemost
; 119(11): 1849-1859, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31461750
14.
Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry.
Eur J Surg Oncol
; 44(8): 1191-1198, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29685755
15.
Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer.
Oncotarget
; 6(8): 6151-9, 2015 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25730906
Resultados
1 -
15
de 15
1
Próxima >
>>